Mixed
GLP-1 receptor agonists for obesity treatment cause significant loss of lean body mass (approximately 20-25% of total weight reduction in men and 10-15% in women) and bone density, particularly when rapid weight loss occurs without structured resistance training.
If you are taking a GLP-1 medication for weight loss, you will likely lose some muscle along with fat. To protect your strength and metabolism, you must engage in resistance training (weight lifting) and ensure you are eating enough protein. This is especially important if you are losing weight quickly.
Rapid weight reduction from (but not limited to) GLP-1 use frequently leads to loss of both fat and muscle mass... Modeling data suggest that loss of muscle mass varies by sex, representing 10–15 % of total weight reduction in women and 20–25 % of total weight reduction in men, in the absence of structured strength training [60].
Why this rating
Based on multiple randomized controlled trials (STEP 1, SURMOUNT 1) and modeling data cited in the advisory.
Source
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Dariush Mozaffarian et al. · Obesity Pillars · 2025
DOI 10.1016/j.obpill.2025.100181
More from this paper
- Discontinuation of GLP-1 therapy leads to rapid and substantial weight regain, often returning to near baseline levels within one year, highlighting the chronic nature of obesity treatment.Strong
- GLP-1 therapy is associated with significant gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) which are dose-dependent and can lead to discontinuation, although most side effects decrease with continued use.Strong
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →